Title of the moderated networking table:
From Molecule to Companion: Building Digital Patient Support in a Regulated World
Summary of the moderated networking table
Sciensus will host a practical session exploring how digital patient support can become a scalable source of commercial value for biotech, improving adherence, generating real-world evidence and strengthening launch and lifecycle strategy.
Date, time and room information
Monday, May 4, 17:10 - 17:40, room Rio, level 2
Moderator
| Name | Position | Institution |
|---|---|---|
| Katie Duncalf | Director Of Innovation & Market Strategy | Sciensus |
| Lucia Rüdlinger | Head of Regulatory Affairs | VIPS Representative Swiss Pharma Association |
Sciensus
Sciensus AG is a specialised healthcare services provider delivering clinical care at home for people living with rare diseases across Switzerland. Our qualified nurses provide infusion and injection therapies in patients’ homes, support them throughout the course of treatment, and make an important contribution to patient safety, continuity of care and quality of life.
